Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07207122 · ClinicalTrials.gov registry record · NA
Effects of Transcranial Ultrasound Stimulation (TUS) on Neurological and Cognitive Outcomes in Neurodegenerative Diseases
A NA study of Parkinson Disease and Mild Cognitive Impairment, sponsored by Sanmai Technologies PBC dba Sanmai.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07207122 is a NA study of Parkinson Disease and Mild Cognitive Impairment that is actively recruiting participants, run by Sanmai Technologies PBC dba Sanmai. The registered enrollment target is 20 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07207122, a NA study of Parkinson Disease and Mild Cognitive Impairment, is actively recruiting participants, sponsored by Sanmai Technologies PBC dba Sanmai.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the safety and efficacy of transcranial focused ultrasound neuromodulation in improving neural function, cognitive and behavioral performance, and quality of life for patients with neurodegenerative diseases.
Conditions Studied
Interventions
- DEVICE Transcranial focused ultrasound modulation administered to a region involved in disease pathology.
Study Locations (1)
California
- The Regenesis Project - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-10-08 |
| Est. Completion | 2026-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07207122
The ClinicalTrials.gov registry entry for NCT07207122 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The listed sponsor is Sanmai Technologies PBC dba Sanmai, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Transcranial focused ultrasound modulation administered to a region involved in disease pathology. is the first listed.
NCT07207122 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07207122 about?
NCT07207122 is a clinical study titled "Effects of Transcranial Ultrasound Stimulation (TUS) on Neurological and Cognitive Outcomes in Neurodegenerative Diseases". The purpose of this study is to evaluate the safety and efficacy of transcranial focused ultrasound neuromodulation in improving neural function, cognitive and behavioral performance, and quality of life for patients with neurodegenerative diseases.
What is the current status of trial NCT07207122?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-10-08. Estimated completion is 2026-08.
What conditions does trial NCT07207122 study?
This clinical trial studies the following conditions: Parkinson Disease, Mild Cognitive Impairment, Parkinson's Disease (PD), Alzheimer's Disease (AD), Parkinson's Disease Dementia (PDD).
What interventions are being tested in trial NCT07207122?
The interventions under investigation include: Transcranial focused ultrasound modulation administered to a region involved in disease pathology. (DEVICE).
Who is sponsoring clinical trial NCT07207122?
This trial is sponsored by Sanmai Technologies PBC dba Sanmai, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07207122 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Neurophysiology of Reward Signaling in Parkinson's Disease
RECRUITING · NA
-
Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease
RECRUITING · NA
-
Rock Steady Boxing: A Community Based In Person Class
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.